{"id":"https://openalex.org/W1968091752","doi":"https://doi.org/10.1159/000139481","title":"Inhibition of Tumor Necrosis Factor-Alpha and lnterleukin-1-Beta Production by Beta-Adrenoceptor Agonists from Lipopolysaccharide- Stimulated Human Peripheral Blood Mononuclear Cells","display_name":"Inhibition of Tumor Necrosis Factor-Alpha and lnterleukin-1-Beta Production by Beta-Adrenoceptor Agonists from Lipopolysaccharide- Stimulated Human Peripheral Blood Mononuclear Cells","alternate_titles":[],"publication_year":2008,"publication_date":"2008-06-10","ids":{"openalex":"https://openalex.org/W1968091752","doi":"https://doi.org/10.1159/000139481","mag":"1968091752","pmid":"https://pubmed.ncbi.nlm.nih.gov/9127437"},"language":"en","primary_location":{"id":"doi:10.1159/000139481","doi":"https://doi.org/10.1159/000139481","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000139481","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968091752"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://gifu-pu.repo.nii.ac.jp/records/11307","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013340536","display_name":"Tomoaki Yoshimura","orcid":"https://orcid.org/0009-0008-2486-8169","observed_orcids":["https://orcid.org/0009-0008-2486-8169"]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomoaki Yoshimura","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Gifu, Japan","Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Gifu, Japan","institution_ids":["https://openalex.org/I4210123703"]},{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109038649","display_name":"Chikako Kurita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chikako Kurita","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064481296","display_name":"Tomomi Nagao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomomi Nagao","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086736337","display_name":"Eiseki Usami","orcid":"https://orcid.org/0000-0002-3422-3072","observed_orcids":["https://orcid.org/0000-0002-3422-3072"]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eiseki Usami","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110403118","display_name":"Toshiya Nakao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toshiya Nakao","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089489671","display_name":"Shino Watanabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shino Watanabe","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110190801","display_name":"Joji Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joji Kobayashi","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109317207","display_name":"Futoshi Yamazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123703","display_name":"Ogaki Municipal Hospital","ror":"https://ror.org/0266t0867","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123703"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Futoshi Yamazaki","raw_affiliation_strings":["Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Ogaki Municipal Hospital, Ogaki, Gifu, and","institution_ids":["https://openalex.org/I4210123703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101823124","display_name":"Hiroyuki Tanaka","orcid":"https://orcid.org/0000-0003-3777-6112","observed_orcids":["https://orcid.org/0000-0003-3777-6112","https://orcid.org/0009-0001-4904-6822"]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroyuki Tanaka","raw_affiliation_strings":["Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan","institution_ids":["https://openalex.org/I173865709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106134493","display_name":"Naoki Inagaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Naoki Inagaki","raw_affiliation_strings":["Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan","institution_ids":["https://openalex.org/I173865709"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110215376","display_name":"H. Nagai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroich Nagai","raw_affiliation_strings":["Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan","institution_ids":["https://openalex.org/I173865709"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4242,"has_fulltext":false,"cited_by_count":76,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.79249112,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"54","issue":"3","first_page":"144","last_page":"152"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.41429999470710754,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.41429999470710754,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.10939999669790268,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12580","display_name":"Vagus Nerve Stimulation Research","score":0.066600002348423,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-adrenergic-agonists","display_name":"beta-adrenergic agonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9900000095367432},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":1.0},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9409999847412109},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.984000027179718},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.746999979019165},{"id":"https://openalex.org/keywords/procaterol","display_name":"procaterol","score":0.8479999899864197},{"id":"https://openalex.org/keywords/clenbuterol","display_name":"clenbuterol","score":0.9829999804496765},{"id":"https://openalex.org/keywords/fenoterol","display_name":"fenoterol","score":0.9850000143051147},{"id":"https://openalex.org/keywords/terbutaline","display_name":"terbutaline","score":0.9990000128746033},{"id":"https://openalex.org/keywords/theophylline","display_name":"theophylline","score":0.9710000157356262},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.953000009059906},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.7599999904632568},{"id":"https://openalex.org/keywords/allergic-inflammation","display_name":"allergic inflammation","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6844357848167419},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6519404649734497},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.6117904186248779},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6044554710388184},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.576863706111908},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.48060342669487},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4100457727909088},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4057365953922272},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.35906606912612915},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3069570064544678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3005182147026062},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08327043056488037},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.05736261606216431},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000318","descriptor_name":"Adrenergic beta-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002469","descriptor_name":"Cell Separation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002976","descriptor_name":"Clenbuterol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005280","descriptor_name":"Fenoterol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D011433","descriptor_name":"Propranolol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013726","descriptor_name":"Terbutaline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016209","descriptor_name":"Interleukin-8","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016209","descriptor_name":"Interleukin-8","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017265","descriptor_name":"Procaterol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1159/000139481","doi":"https://doi.org/10.1159/000139481","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000139481","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},{"id":"pmid:9127437","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9127437","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:01402:0002664258","doi":null,"is_oa":true,"landing_page_url":"https://gifu-pu.repo.nii.ac.jp/records/11307","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The annual proceedings of Gifu College of Pharmacy","raw_type":"departmental bulletin paper"},{"id":"mag:1524941220","doi":null,"is_oa":false,"landing_page_url":"https://gifu-pu.repo.nii.ac.jp/?action=repository_action_common_download&item_id=11307&item_no=1&attribute_id=18&file_no=1","pdf_url":null,"source":{"id":"https://openalex.org/S4306532070","display_name":"The annual proceedings of Gifu College of Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The annual proceedings of Gifu College of Pharmacy","raw_type":null},{"id":"mag:3152318875","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/120005563173","pdf_url":null,"source":{"id":"https://openalex.org/S4306548071","display_name":"\u5c90\u961c\u85e5\u79d1\u5927\u5b78\u7d00\u8981 = The annual proceedings of Gifu College of Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u5c90\u961c\u85e5\u79d1\u5927\u5b78\u7d00\u8981 = The annual proceedings of Gifu College of Pharmacy","raw_type":null}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01402:0002664258","doi":null,"is_oa":true,"landing_page_url":"https://gifu-pu.repo.nii.ac.jp/records/11307","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The annual proceedings of Gifu College of Pharmacy","raw_type":"departmental bulletin paper"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2238861146","https://openalex.org/W2075999576","https://openalex.org/W2070891589","https://openalex.org/W1486943611","https://openalex.org/W2062780494","https://openalex.org/W2949127338","https://openalex.org/W1998516103","https://openalex.org/W2432989836","https://openalex.org/W2017121225"],"abstract_inverted_index":{"The":[0,32,122],"effects":[1],"of":[2,9,74,118,124,144,160,176,184],"beta-adrenoceptor":[3,139],"agonists":[4],"(beta-agonists)":[5],"on":[6,54],"the":[7,72,101,116,142,158,182],"production":[8,44,58,73,83,93,129,149,159],"tumor":[10],"necrosis":[11],"factor-alpha":[12],"(TNF-alpha),":[13],"interleukin-1":[14],"beta":[15,43,92,128,148],"(IL-1":[16],"beta)":[17],"and":[18,37,41,76,107,126,146,166],"interleukin-8":[19],"(IL-8)":[20],"by":[21,88,130,150,169],"lipopolysaccharide":[22],"(LPS)-stimulated":[23],"human":[24],"peripheral":[25],"blood":[26],"mononuclear":[27],"cells":[28],"(PBMCs)":[29],"were":[30],"investigated.":[31],"beta-agonists,":[33],"procaterol,":[34],"clenbuterol,":[35],"fenoterol":[36],"terbutaline,":[38],"inhibited":[39,60,71,87],"TNF-alpha":[40,57,75,82,125,145,165],"IL-1":[42,64,77,91,127,147,167],"in":[45,112,181],"a":[46,138],"concentration-dependent":[47],"manner,":[48],"whereas":[49,90],"they":[50],"had":[51],"no":[52],"effect":[53,117],"IL-8":[55],"production.":[56],"was":[59,84,120,132],"more":[61],"potently":[62],"than":[63],"beta.":[65],"Dibutyryl":[66],"cyclic":[67],"AMP":[68],"(dbcAMP)":[69],"also":[70],"beta,":[78,168],"but":[79,115],"not":[80],"IL-8.":[81],"almost":[85],"completely":[86],"dbcAMP,":[89],"appeared":[94],"to":[95],"be":[96,179],"partially":[97],"refractory":[98],"even":[99],"at":[100],"highest":[102],"concentration":[103],"examined.":[104],"Both":[105],"procaterol":[106,119,131],"theophylline":[108],"elevated":[109],"cAMP":[110,172],"levels":[111],"LPS-stimulated":[113],"PBMCs,":[114],"limited.":[121],"inhibition":[123,143],"additively":[133],"potentiated":[134],"with":[135],"theophylline.":[136],"dl-Propranolol,":[137],"antagonist,":[140],"abrogated":[141],"procaterol.":[151],"These":[152,174],"results":[153],"indicate":[154],"that":[155],"beta-agonists":[156,177],"inhibit":[157],"proinflammatory":[161],"cytokines,":[162],"such":[163],"as":[164],"elevating":[170],"intracellular":[171],"levels.":[173],"properties":[175],"might":[178],"beneficial":[180],"treatment":[183],"allergic":[185],"inflammation.":[186]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1968091752","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
